These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26783333)

  • 1. Prisons face hep C-treatment funding crisis.
    Webster P
    CMAJ; 2016 Feb; 188(3):178-179. PubMed ID: 26783333
    [No Abstract]   [Full Text] [Related]  

  • 2. Enforcement of Legal Remedies to Secure Hepatitis C Virus Treatment With Direct-Acting Antiviral Therapies in Correctional Facilities and Medicaid Programs.
    Greenwald R; Waters P; Cayer S
    Public Health Rep; 2020; 135(1_suppl):44S-49S. PubMed ID: 32735189
    [No Abstract]   [Full Text] [Related]  

  • 3. The Introduction of Prison Needle and Syringe Programs in Canadian Federal Prisons.
    Peternelj-Taylor C
    J Forensic Nurs; 2018; 14(3):123-125. PubMed ID: 30130313
    [No Abstract]   [Full Text] [Related]  

  • 4. Optimism for prison syringe programs.
    Collier R
    CMAJ; 2016 Aug; 188(11):E249. PubMed ID: 27378460
    [No Abstract]   [Full Text] [Related]  

  • 5. Conservative government scuttles needle exchange.
    Kondro W
    CMAJ; 2007 Jan; 176(3):308. PubMed ID: 17261817
    [No Abstract]   [Full Text] [Related]  

  • 6. Scale-up of hepatitis C treatment in prisons is key to national elimination.
    Papaluca T; Hellard ME; Thompson AJV; Lloyd AR
    Med J Aust; 2019 May; 210(9):391-393.e1. PubMed ID: 30968417
    [No Abstract]   [Full Text] [Related]  

  • 7. [Costs of modern treatment of chronic hepatitis C].
    Stiefelhagen P; Sarrazin C
    Med Monatsschr Pharm; 2015 Sep; 38(9):347-9. PubMed ID: 26731852
    [No Abstract]   [Full Text] [Related]  

  • 8. [Short-time hepatitis C treatment and drug abuse].
    Kristensen Ø; Rysstad O; Gallefoss F
    Tidsskr Nor Laegeforen; 2009 Dec; 129(23):2498; author reply 2499. PubMed ID: 19997144
    [No Abstract]   [Full Text] [Related]  

  • 9. Newest Treatments for Hepatitis C: How Can We Manage Sustainability?
    Messori A
    Clin Infect Dis; 2015 Dec; 61(12):1891-2. PubMed ID: 26261204
    [No Abstract]   [Full Text] [Related]  

  • 10. Hepatitis C treatment in drug users: perception versus evidence.
    Sylvestre D
    Eur J Gastroenterol Hepatol; 2006 Feb; 18(2):129-30. PubMed ID: 16394792
    [No Abstract]   [Full Text] [Related]  

  • 11. Hepatitis C Virus Treatment and Injection Drug Users: It Is Time to Separate Fact From Fiction.
    McCance-Katz EF; Valdiserri RO
    Ann Intern Med; 2015 Aug; 163(3):224-5. PubMed ID: 26120801
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Messori.
    Rein DB
    Clin Infect Dis; 2015 Dec; 61(12):1892-3. PubMed ID: 26261202
    [No Abstract]   [Full Text] [Related]  

  • 13. [Economic evaluation of combined therapy in chronic hepatitis C].
    Casado MA; Buti M; Fosbrook L; Esteban R
    Gastroenterol Hepatol; 2000 Feb; 23 Suppl 1():57-62. PubMed ID: 11968346
    [No Abstract]   [Full Text] [Related]  

  • 14. Prevalence of hepatitis C and pre-testing awareness of hepatitis C status in 1500 consecutive PWID participants at the Stockholm needle exchange program.
    Kåberg M; Hammarberg A; Lidman C; Weiland O
    Infect Dis (Lond); 2017 Oct; 49(10):728-736. PubMed ID: 28574295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 'HepConomics': cost-effective, indeed, but how can we pay for it?
    Athanasakis K; Petrakis I; Kyriopoulos J
    J Viral Hepat; 2015 Aug; 22(8):682. PubMed ID: 25727161
    [No Abstract]   [Full Text] [Related]  

  • 16. Adopting more systematic approaches to hepatitis C treatment in correctional facilities.
    Hammett TM
    Ann Intern Med; 2003 Feb; 138(3):235-6. PubMed ID: 12558365
    [No Abstract]   [Full Text] [Related]  

  • 17. Five Questions Concerning Managing Hepatitis C in the Justice System: Finding Practical Solutions for Hepatitis C Virus Elimination.
    Spaulding AC; Adee MG; Lawrence RT; Chhatwal J; von Oehsen W
    Infect Dis Clin North Am; 2018 Jun; 32(2):323-345. PubMed ID: 29778259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Is hepatitis C important for drug addicts?].
    Aavitsland P
    Tidsskr Nor Laegeforen; 2009 Aug; 129(16):1623. PubMed ID: 19721475
    [No Abstract]   [Full Text] [Related]  

  • 19. Cost-effectiveness of treating chronic hepatitis C virus with direct-acting antivirals in people who inject drugs in Australia.
    Scott N; Iser DM; Thompson AJ; Doyle JS; Hellard ME
    J Gastroenterol Hepatol; 2016 Apr; 31(4):872-82. PubMed ID: 26514998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Why is there still hepatitis C transmission in Australian prisons? A case report.
    Harkness B; Levy M; Evans R; Wenke J
    Harm Reduct J; 2017 Nov; 14(1):75. PubMed ID: 29178927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.